ShopMed24
close
Language
Medical buyer reviewing MDR certification documents in a hospital stock room

MDR 2026: What Medical Buyers Need to Know Now

4 min reading time

The Medical Device Regulation (MDR) enters its next phase in 2026. For buyers in hospitals, practices, and care facilities, that means new documentation duties, stricter supplier requirements, and higher liability risks. Here's what matters now.

The Medical Device Regulation (MDR) enters its next phase in 2026. For buyers in hospitals, practices, and care facilities, that means new documentation duties, stricter supplier requirements, and higher liability risks. Here's what matters now.

What is the MDR — and why does it affect buyers?

EU Regulation 2017/745 — known as the Medical Device Regulation, or MDR — replaced the old Medical Devices Directive 93/42/EEC and sets significantly tougher requirements for manufacturers, importers, distributors, and anyone who procures medical devices. While early discussions focused on manufacturers, 2026 is shifting attention to downstream actors: buyers in hospitals, nursing homes, and healthcare institutions are part of the supply chain too, and must be able to evidence their due diligence.

In concrete terms: if you buy a medical device, you must be able to demonstrate its MDR compliance at any time. That applies to everything from band-aids and syringes to surgical tables.

Key 2026 changes at a glance

1. Extended transition periods — with conditions attached

Regulation (EU) 2023/607 extended transition periods for existing products — until December 2027 for Class III and implantable Class IIb devices, and until December 2028 for other Class IIb, Class IIa, and Class Ir/Im/Is devices. The catch: the manufacturer must have filed an application with a Notified Body by May 2024 and operate a QMS compliant with MDR.

For buyers, this means: don't assume "we still have a transition period." Actively ask your supplier whether the conditions are met. Otherwise, the product loses its marketability — and you're stuck holding non-compliant inventory.

2. UDI compliance becomes routine

Unique Device Identification (UDI) has been phased in since 2021. In 2026, it's mandatory in practice for nearly all classes. Buyers must capture UDI data in their procurement systems and feed it to EUDAMED.

3. Stricter vigilance reporting duties

Incidents involving medical devices must be reported faster and in more detail. Hospitals need clear internal processes — and their suppliers need to cooperate.

4. Supplier evaluation becomes mandatory

If you can't qualify a supplier, you can no longer do business with them for critical products. MDR requires documented qualification processes across the entire supply chain.

What buyers should do right now

Make supplier audits standard practice

Don't just file conformity declarations away. Actively request the following documents:

  • Current CE certificate per MDR (no longer MDD)
  • ISO 13485 certification of the manufacturer
  • UDI master data for every product
  • Safety and performance requirements (MDR Annex I)
  • Current technical documentation on request

Review your EUDAMED integration

The European database EUDAMED will activate additional mandatory modules in 2026. Work with your IT team to automate handoff of UDI and vigilance data.

Risk-based procurement

Classify your products by risk (Class I to III) and prioritize your compliance reviews accordingly. A Class I dressing needs less depth than an implantable Class III product — but both need documentation.

Training for your procurement team

MDR knowledge is no longer a specialist domain for the regulatory department. Every buyer should know the basics: classification, CE obligations, UDI, reporting channels.

Common mistakes to avoid

Mistake 1: "The manufacturer is certified."
ISO 13485 is a prerequisite, not a substitute for product-specific MDR compliance. Every product needs its own evidence.

Mistake 2: Relying on old MDD certificates.
Transition periods aren't a free pass. Actively check whether the conditions for the extension are met.

Mistake 3: Imports from non-EU countries without an EU authorized representative.
A non-EU manufacturer needs an EU authorized representative. Without one, the product isn't marketable.

Mistake 4: No documentation of supplier evaluation.
"We've known them for years" won't pass an audit. You need structured, traceable processes.

How ShopMed24 supports you

On ShopMed24, we work exclusively with verified suppliers from the DACH region. Before activating any vendor, we check:

  • Valid commercial register entries
  • Current ISO 13485 certification
  • MDR-compliant product documentation
  • EU registration or appointed EU authorized representative

That makes your procurement not just easier, but legally safer. Every product on our platform comes with its compliance data attached — UDI, CE class, and manufacturer are transparently documented.

Conclusion

MDR 2026 is no longer an abstract regulatory topic — it directly affects every buyer in healthcare. Those who set up supplier evaluation, documentation processes, and team training now will avoid costly bottlenecks and liability risks in the second half of the year.

Our tip: Start this week with a supplier list and a simple compliance checklist. The people who structure things now will sleep better in 2027.

→ Discover MDR-compliant products on ShopMed24

Tags

Leave a comment

Leave a comment


    B2B Login

    Forgot your password?

    No business account yet?
    Create a B2B account for exclusive pricing